Ilana Belzer
Chief Operating Officer at BIOHARVEST SCIENCES INC.
Net worth: 3 536 $ as of 2024-04-29
Ilana Belzer active positions
Companies | Position | Start | End |
---|---|---|---|
BIOHARVEST SCIENCES INC. | Chief Operating Officer | 2023-04-18 | - |
Career history of Ilana Belzer
Former positions of Ilana Belzer
Companies | Position | Start | End |
---|---|---|---|
Bio Harvest Ltd.
Bio Harvest Ltd. Food: Specialty/CandyConsumer Non-Durables Bio Harvest Ltd. operates as a consumer health company. It manufactures bio food products. The firm uses an all-natural manufacturing process to grow actual cells from health promoting fruits and vegetables species. The company was founded by Zaki Rakib and Yochi Hagay and is headquartered in Rehovot, Israel. | Chief Operating Officer | 2012-09-30 | 2015-08-31 |
Procognia Ltd.
Procognia Ltd. Miscellaneous Commercial ServicesCommercial Services Procognia Ltd. provides technology for the development of glycoprotein drugs. It uses protein arrays to understand the function of proteins and their post-translational modifications. Utilizing technologies based around proteins arrays, they provide both the means for disease mechanisms and the discovery and development of drugs to treat those diseases. Procognia uses protein arrays to understand the function of proteins and their post-translational modifications, particularly glycosylation | Chief Tech/Sci/R&D Officer | - | - |
Omrix Biopharmaceuticals Ltd.
Omrix Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Omrix Biopharmaceuticals Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The company is based in Tel Aviv, Israel. | Corporate Officer/Principal | - | - |
SOLEGREEN | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov. | Corporate Officer/Principal | - | - |
COLLPLANT BIOTECHNOLOGIES LTD. | Chief Operating Officer | 2015-09-30 | - |
Training of Ilana Belzer
Tel-Aviv University | Doctorate Degree |
Statistics
International
Israel | 7 |
United Kingdom | 2 |
Canada | 2 |
Operational
Chief Operating Officer | 4 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
SOLEGREEN | Utilities |
BIOHARVEST SCIENCES INC. | Process Industries |
Private companies | 4 |
---|---|
Bio Harvest Ltd.
Bio Harvest Ltd. Food: Specialty/CandyConsumer Non-Durables Bio Harvest Ltd. operates as a consumer health company. It manufactures bio food products. The firm uses an all-natural manufacturing process to grow actual cells from health promoting fruits and vegetables species. The company was founded by Zaki Rakib and Yochi Hagay and is headquartered in Rehovot, Israel. | Consumer Non-Durables |
Interpharm Laboratories Ltd.
Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov. | Health Technology |
Omrix Biopharmaceuticals Ltd.
Omrix Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Omrix Biopharmaceuticals Ltd. is an Israeli pharmaceutical company that manufactures pharmaceutical products. The company is based in Tel Aviv, Israel. | Health Technology |
Procognia Ltd.
Procognia Ltd. Miscellaneous Commercial ServicesCommercial Services Procognia Ltd. provides technology for the development of glycoprotein drugs. It uses protein arrays to understand the function of proteins and their post-translational modifications. Utilizing technologies based around proteins arrays, they provide both the means for disease mechanisms and the discovery and development of drugs to treat those diseases. Procognia uses protein arrays to understand the function of proteins and their post-translational modifications, particularly glycosylation | Commercial Services |
- Stock Market
- Insiders
- Ilana Belzer
- Experience